InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MOHANTY ADITYA P., Chief Executive Officer. Insider active across 2 companies, notably PROGENITY, INC.. Cumulatively, 9 reports have been logged. History available since 8 November 2021. The latest transaction was filed on 15 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
70,883 shares@ US$0.679.3% of flowCommon StockSEC:0000950170-24-098048:0
819,000 shares0Common StockSEC:0000950170-24-015858:0
117,881 shares@ US$3.1473.3% of flowCommon StockSEC:0000950170-23-043221:0
11,249 shares@ US$3.357.5% of flowCommon StockSEC:0000950170-23-022770:0
155,550 shares0Common StockSEC:0000899243-23-009035:0
178 sharesSeries X Preferred StockSEC:0000899243-23-000967:0
175,071 shares@ US$0.279.9% of flowCommon StockSEC:0000899243-22-036078:0
1,562,500 shares0Common StockSEC:0000899243-22-018429:0
1,412,429 shares0Common StockSEC:0000899243-21-044665:0
9 of 9 declarations
About MOHANTY ADITYA P.
Aditya P. Mohanty is the Chief Executive Officer of Progenity, Inc. and Biora Therapeutics, Inc. In this role, he oversees the global operations and strategy of both companies. Progenity, Inc. is a biotechnology company specializing in genetic testing, while Biora Therapeutics, Inc. focuses on therapeutic solutions. Mohanty plays a crucial role in strategic direction and innovation, thereby contributing to the improvement of healthcare.
